Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Shiao Li Oei"'
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Lung cancer (LC) is associated with high mortality and poor quality of life (QoL). The disease as well as oncological treatments such as radiation and chemotherapy with adverse effects can impair the QoL of patients. Add-on treatm
Externí odkaz:
https://doaj.org/article/6fed87d2ce7147c09bed4977eca6f2f2
Self-Reported Baseline Quality of Life Mirrors Treatment-Specific Characteristics of Cancer Patients
Autor:
Anja Thronicke, Shiao Li Oei, Gerrit Grieb, Patricia Grabowski, Juliane Roos, Friedemann Schad
Publikováno v:
Cancers, Vol 15, Iss 24, p 5763 (2023)
Background: Baseline quality of life (bQL) has been shown to be a predictor of the clinical outcome of oncological patients. The primary objective of the present study was to examine the role of bQL as a treatment predictor in oncological patients. M
Externí odkaz:
https://doaj.org/article/d16cebfd9a3c4cf6bcae6a3531e10c4a
Autor:
Shiao Li Oei, Anja Thronicke, Jessica Groß, Thomas Rieser, Sarah Becker, Patricia Grabowski, Gerrit Grieb, Harald Matthes, Friedemann Schad
Publikováno v:
Cancers, Vol 15, Iss 23, p 5678 (2023)
Background: Chronic cancer-related fatigue is difficult to manage in breast cancer survivors. The tango trial showed that a six-week tango Argentino program was effective in reducing fatigue and improving quality of life, and here we investigated the
Externí odkaz:
https://doaj.org/article/2fbb0728d4a64e5e9d81a109d2ccbc5e
Autor:
Shiao Li Oei, Thomas Rieser, Sarah Becker, Jessica Groß, Harald Matthes, Friedemann Schad, Anja Thronicke
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background The majority of breast cancer patients suffer from persistent impairments after completion of their primary oncological therapy. Cancer-related fatigue (CRF) in particular is a multidimensional syndrome having a profound negative
Externí odkaz:
https://doaj.org/article/58fd5e2eb30e4204a9b80200a8c55257
Autor:
Friedemann Schad, Thomas Rieser, Sarah Becker, Jessica Groß, Harald Matthes, Shiao Li Oei, Anja Thronicke
Publikováno v:
Cancers, Vol 15, Iss 11, p 2920 (2023)
Background: Persistent impairments of quality of life—in particular, cancer-associated fatigue—are a major limitation for breast cancer survivors. As physical activity and mindfulness interventions have been shown to be effective in reducing fati
Externí odkaz:
https://doaj.org/article/cfcf9e47c5b44c98af5ade3b0b517a0c
Autor:
Shiao Li Oei, Friedemann Schad
Publikováno v:
Cancers, Vol 15, Iss 4, p 1116 (2023)
Numerous clinical studies have been conducted to improve the outcomes of patients suffering from pancreatic cancer. Different approaches using targeted therapeutic strategies and precision medicine methods have been investigated, and synergies and fu
Externí odkaz:
https://doaj.org/article/21682cf95b934809b6b4ca4609c1075d
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Introduction: Cancer-related fatigue (CRF) occurs frequently in breast cancer patients. The aim of this real-world study was to analyze the longitudinal changes of CRF in breast cancer patients receiving an integrative medicine program, which include
Externí odkaz:
https://doaj.org/article/41d610addce3479eb92992bdc0cff4ac
Autor:
Shiao Li Oei PhD, Anja Thronicke PhD, Matthias Kröz MD, Philipp von Trott MD, Friedemann Schad MD, Harald Matthes MD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Introduction: Viscum album L extracts (VA) are frequently used in integrative oncology. Aim of this study was to evaluate the impact of add-on VA applications on various patient-reported outcome measures. Methods: A longitudinal real-world study was
Externí odkaz:
https://doaj.org/article/bcb7e9ec0e174bf1b492e20ed6969673
Autor:
Shiao Li Oei PhD, Anja Thronicke PhD, Matthias Kröz MD, Harald Matthes MD, Friedemann Schad MD
Publikováno v:
Integrative Cancer Therapies, Vol 18 (2019)
Background: Viscum album L (VA, mistletoe) extracts are commonly used in integrative oncology. Here the clinical safety profile of additional VA-treatments to standard care in cancer patients with preexisting autoimmune diseases was analyzed. Methods
Externí odkaz:
https://doaj.org/article/8f18bf0f0f304d3ea419bfe0eb278c12
Publikováno v:
Medicines, Vol 5, Iss 3, p 100 (2018)
Background: Despite improvement of tumor response rates, targeted therapy may induce toxicities in cancer patients. Recent studies indicate amelioration of adverse events (AEs) by add-on mistletoe (Viscum album L., VA) in standard oncological treatme
Externí odkaz:
https://doaj.org/article/6cc1b2e76ff64c34ade49923e90e29e2